Precision Biosensor, Inc. (KOSDAQ:335810)
South Korea
· Delayed Price · Currency is KRW 2,965.00
-5.00 (-0.17%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Clinical Chemical | 12.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Chemical Growth | -15.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunodiagnostic | 6.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunodiagnostic Growth | 21.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Goods and Services | 336.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Goods and Services Growth | 2.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunodiagnostic Testers and Diagnostic Reagents Manufactured Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunodiagnostic Testers and Diagnostic Reagents Manufactured Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunodiagnostic Testers and Diagnostic Reagents Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunodiagnostic Testers and Diagnostic Reagents Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Other | 4.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 79.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 7.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | -17.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 5.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -0.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 852.42M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -21.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 836.47M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -60.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 4.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 79.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Russia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Russia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Czech Republic | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Czech Republic Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Iran | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Mexico | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Austria | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|